Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement

J L Pouchelon1, C E Atkins2, C Bussadori3

  • 1Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, Unité de Cardiologie d'Alfort, Centre Hospitalier Universitaire Vétérinaire d'Alfort (CHUVA), Maisons-Alfort 94704, France.

Insights

Veterinary experts established consensus on cardiovascular-renal disorders (CvRD) in dogs and cats. This research provides initial guidelines for defining, diagnosing, and managing CvRD, improving animal cardiovascular and kidney health.

Area of Science:

  • Veterinary Medicine
  • Cardiology
  • Nephrology

Background:

  • The complex interplay between cardiovascular and renal systems is recognized in human medicine as cardiorenal syndrome (CRS).
  • The veterinary profession lacks formal definitions and understanding of CRS, termed cardiovascular-renal disorders (CvRD) in dogs and cats.
  • Investigating the existence and importance of CvRD in veterinary patients is crucial.

Framework:

  • A consensus group of veterinary cardiologists and nephrologists was formed to address CvRD.
  • The Delphi methodology was employed to achieve consensus on the definition, pathophysiology, diagnosis, and management of CvRD.
  • The process aimed to establish formal guidelines for veterinary CvRD.

Implementation:

  • A literature review preceded the Delphi method.
  • Thirteen candidate statements regarding CvRD in dogs and cats were evaluated.
  • Consensus was sought through a modified Delphi approach, relying on expert opinion and existing data due to limited specific studies.

Implications:

  • Eleven of the thirteen statements achieved consensus, forming the basis for initial CvRD guidelines.
  • The developed consensus statements provide a framework for defining, classifying, diagnosing, and managing CvRD in veterinary patients.
  • This work aims to stimulate further research and enhance the understanding and treatment of cardiovascular-renal disorders in dogs and cats.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
656
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.6K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
970
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772